This episode of the Cannabis Review podcast is an interview with Nicholas Milne, co-founder and CSO at Octarine, a Danish company specializing in yeast fermentation and synthetic biology to produce new compounds. Octarine uses yeast to produce psychedelics like psilocybin, offering a more consistent, sustainable, and cost-effective method than extraction from mushrooms.
They aim to provide GMP-grade psilocybin for dollars per gram. For cannabinoids, Octarine uses fermentation to convert natural cannabinoids into new compounds with improved properties like water solubility, stability, and high bioavailability. They work with consumer brands and pharmaceutical companies to advance products made by fermentation down the value chain.